Sawtooth Solutions LLC trimmed its position in shares of CVS Health Corporation (NYSE:CVS) by 0.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,813 shares of the pharmacy operator’s stock after selling 130 shares during the quarter. Sawtooth Solutions LLC’s holdings in CVS Health Corporation were worth $1,514,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Burney Co. boosted its position in CVS Health Corporation by 11.7% during the second quarter. Burney Co. now owns 104,518 shares of the pharmacy operator’s stock worth $8,390,000 after purchasing an additional 10,933 shares in the last quarter. Nuance Investments LLC purchased a new stake in CVS Health Corporation during the second quarter worth $2,973,000. Sequoia Financial Advisors LLC boosted its position in CVS Health Corporation by 0.8% during the second quarter. Sequoia Financial Advisors LLC now owns 6,406 shares of the pharmacy operator’s stock worth $515,000 after purchasing an additional 53 shares in the last quarter. Artemis Investment Management LLP purchased a new stake in CVS Health Corporation during the second quarter worth $7,348,000. Finally, Bronfman E.L. Rothschild L.P. boosted its position in CVS Health Corporation by 48.0% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 19,189 shares of the pharmacy operator’s stock worth $1,544,000 after purchasing an additional 6,226 shares in the last quarter. Institutional investors own 82.04% of the company’s stock.

In other CVS Health Corporation news, EVP Thomas M. Moriarty sold 90,267 shares of the company’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the completion of the sale, the executive vice president now directly owns 70,102 shares in the company, valued at $5,580,820.22. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO David M. Denton sold 237,078 shares of the company’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $79.65, for a total value of $18,883,262.70. Following the sale, the chief financial officer now owns 141,096 shares of the company’s stock, valued at $11,238,296.40. The disclosure for this sale can be found here. Insiders have sold 716,625 shares of company stock valued at $58,318,431 over the last 90 days. 0.61% of the stock is currently owned by insiders.

CVS has been the topic of a number of research analyst reports. SunTrust Banks, Inc. set a $85.00 target price on CVS Health Corporation and gave the stock a “buy” rating in a research report on Thursday, October 12th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $95.00 target price on shares of CVS Health Corporation in a research report on Monday, October 9th. Mizuho set a $90.00 target price on CVS Health Corporation and gave the stock a “buy” rating in a research report on Tuesday, October 24th. Cowen and Company set a $86.00 target price on CVS Health Corporation and gave the stock a “buy” rating in a research report on Sunday, October 29th. Finally, Needham & Company LLC upgraded CVS Health Corporation from a “hold” rating to a “buy” rating and boosted their target price for the stock from $69.02 to $79.00 in a research report on Friday. One research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $85.82.

ILLEGAL ACTIVITY WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/11/14/cvs-health-corporation-cvs-shares-sold-by-sawtooth-solutions-llc.html.

CVS Health Corporation (CVS) opened at $71.48 on Tuesday. CVS Health Corporation has a 12-month low of $66.45 and a 12-month high of $84.72. The firm has a market capitalization of $71,912.30, a PE ratio of 12.43, a P/E/G ratio of 1.22 and a beta of 0.86. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.01. The company had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The firm’s revenue was up 3.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.64 earnings per share. analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.80%. CVS Health Corporation’s dividend payout ratio is presently 41.32%.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.